These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 17215446)

  • 1. Chronic activation of peroxisome proliferator-activated receptor-alpha with fenofibrate prevents alterations in cardiac metabolic phenotype without changing the onset of decompensation in pacing-induced heart failure.
    Labinskyy V; Bellomo M; Chandler MP; Young ME; Lionetti V; Qanud K; Bigazzi F; Sampietro T; Stanley WC; Recchia FA
    J Pharmacol Exp Ther; 2007 Apr; 321(1):165-71. PubMed ID: 17215446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carnitine palmitoyl transferase-I inhibition prevents ventricular remodeling and delays decompensation in pacing-induced heart failure.
    Lionetti V; Linke A; Chandler MP; Young ME; Penn MS; Gupte S; d'Agostino C; Hintze TH; Stanley WC; Recchia FA
    Cardiovasc Res; 2005 Jun; 66(3):454-61. PubMed ID: 15914110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The PPARalpha activator fenofibrate slows down the progression of the left ventricular dysfunction in porcine tachycardia-induced cardiomyopathy.
    Brigadeau F; Gelé P; Wibaux M; Marquié C; Martin-Nizard F; Torpier G; Fruchart JC; Staels B; Duriez P; Lacroix D
    J Cardiovasc Pharmacol; 2007 Jun; 49(6):408-15. PubMed ID: 17577106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of peroxisome proliferator-activated receptor-alpha by fenofibrate prevents myocardial dysfunction during endotoxemia in rats.
    Jozefowicz E; Brisson H; Rozenberg S; Mebazaa A; Gelé P; Callebert J; Lebuffe G; Vallet B; Bordet R; Tavernier B
    Crit Care Med; 2007 Mar; 35(3):856-63. PubMed ID: 17255874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial fibrosis and diastolic dysfunction in deoxycorticosterone acetate-salt hypertensive rats is ameliorated by the peroxisome proliferator-activated receptor-alpha activator fenofibrate, partly by suppressing inflammatory responses associated with the nuclear factor-kappa-B pathway.
    Ogata T; Miyauchi T; Sakai S; Takanashi M; Irukayama-Tomobe Y; Yamaguchi I
    J Am Coll Cardiol; 2004 Apr; 43(8):1481-8. PubMed ID: 15093887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of simvastatin on the development of the atrial fibrillation substrate in dogs with congestive heart failure.
    Shiroshita-Takeshita A; Brundel BJ; Burstein B; Leung TK; Mitamura H; Ogawa S; Nattel S
    Cardiovasc Res; 2007 Apr; 74(1):75-84. PubMed ID: 17270161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuation of cardiac dysfunction by a PPAR-alpha agonist is associated with down-regulation of redox-regulated transcription factors.
    Ichihara S; Obata K; Yamada Y; Nagata K; Noda A; Ichihara G; Yamada A; Kato T; Izawa H; Murohara T; Yokota M
    J Mol Cell Cardiol; 2006 Aug; 41(2):318-29. PubMed ID: 16806263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of angiotensinogen in the myocardium induces downregulation of the fatty acid oxidation pathway.
    Pellieux C; Aasum E; Larsen TS; Montessuit C; Papageorgiou I; Pedrazzini T; Lerch R
    J Mol Cell Cardiol; 2006 Sep; 41(3):459-66. PubMed ID: 16859699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fenofibrate modulates cardiac and hepatic metabolism and increases ischemic tolerance in diet-induced obese mice.
    Aasum E; Khalid AM; Gudbrandsen OA; How OJ; Berge RK; Larsen TS
    J Mol Cell Cardiol; 2008 Jan; 44(1):201-9. PubMed ID: 17931655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PPAR agonists treatment is effective in a nonalcoholic fatty liver disease animal model by modulating fatty-acid metabolic enzymes.
    Seo YS; Kim JH; Jo NY; Choi KM; Baik SH; Park JJ; Kim JS; Byun KS; Bak YT; Lee CH; Kim A; Yeon JE
    J Gastroenterol Hepatol; 2008 Jan; 23(1):102-9. PubMed ID: 18171348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of an orally effective endothelin-A receptor antagonist in dogs with pacing-induced heart failure.
    McConnell PI; Wang W; Zucker IH
    Nebr Med J; 1996 Nov; 81(11):349-55. PubMed ID: 8979712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired myocardial fatty acid oxidation and reduced protein expression of retinoid X receptor-alpha in pacing-induced heart failure.
    Osorio JC; Stanley WC; Linke A; Castellari M; Diep QN; Panchal AR; Hintze TH; Lopaschuk GD; Recchia FA
    Circulation; 2002 Jul; 106(5):606-12. PubMed ID: 12147544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paradoxical downregulation of the glucose oxidation pathway despite enhanced flux in severe heart failure.
    Lei B; Lionetti V; Young ME; Chandler MP; d'Agostino C; Kang E; Altarejos M; Matsuo K; Hintze TH; Stanley WC; Recchia FA
    J Mol Cell Cardiol; 2004 Apr; 36(4):567-76. PubMed ID: 15081316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic vagus nerve stimulation improves autonomic control and attenuates systemic inflammation and heart failure progression in a canine high-rate pacing model.
    Zhang Y; Popovic ZB; Bibevski S; Fakhry I; Sica DA; Van Wagoner DR; Mazgalev TN
    Circ Heart Fail; 2009 Nov; 2(6):692-9. PubMed ID: 19919995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose-6-phosphate dehydrogenase-derived NADPH fuels superoxide production in the failing heart.
    Gupte SA; Levine RJ; Gupte RS; Young ME; Lionetti V; Labinskyy V; Floyd BC; Ojaimi C; Bellomo M; Wolin MS; Recchia FA
    J Mol Cell Cardiol; 2006 Aug; 41(2):340-9. PubMed ID: 16828794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adiponectin receptors: expression in Zucker diabetic rats and effects of fenofibrate and metformin.
    Metais C; Forcheron F; Abdallah P; Basset A; Del Carmine P; Bricca G; Beylot M
    Metabolism; 2008 Jul; 57(7):946-53. PubMed ID: 18555836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered expression of a limited number of genes contributes to cardiac decompensation during chronic ventricular tachypacing in dogs.
    Ojaimi C; Qanud K; Hintze TH; Recchia FA
    Physiol Genomics; 2007 Mar; 29(1):76-83. PubMed ID: 17164392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant glucagon-like peptide-1 increases myocardial glucose uptake and improves left ventricular performance in conscious dogs with pacing-induced dilated cardiomyopathy.
    Nikolaidis LA; Elahi D; Hentosz T; Doverspike A; Huerbin R; Zourelias L; Stolarski C; Shen YT; Shannon RP
    Circulation; 2004 Aug; 110(8):955-61. PubMed ID: 15313949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Underlying mechanisms of pharmacology and toxicity of a novel PPAR agonist revealed using rodent and canine hepatocytes.
    Guo Y; Jolly RA; Halstead BW; Baker TK; Stutz JP; Huffman M; Calley JN; West A; Gao H; Searfoss GH; Li S; Irizarry AR; Qian HR; Stevens JL; Ryan TP
    Toxicol Sci; 2007 Apr; 96(2):294-309. PubMed ID: 17255113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PPAR-alpha agonist fenofibrate induces renal CYP enzymes and reduces blood pressure and glomerular hypertrophy in Zucker diabetic fatty rats.
    Zhao X; Li LY
    Am J Nephrol; 2008; 28(4):598-606. PubMed ID: 18277067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.